U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab

THE BAJA POSTNEWSROOMSOURCE: PR MEDIA Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter … Sigue leyendo U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of Donanemab